(Q40603620)

22 September 2017

title

Rhinocerebral zygomycosis in a patient with acute lymphoblastic leukemia (English)

1 reference

22 September 2017

1 reference

C Lerchenmüller

1

1 reference

22 September 2017

M Göner

series ordinal

2

1 reference

22 September 2017

T Büchner

series ordinal

3

1 reference

22 September 2017

W E Berdel

series ordinal

4

1 reference

22 September 2017

publication date

1 March 2001

1 reference

22 September 2017

1 reference

22 September 2017

volume

12

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

415-419

1 reference

Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011119018112

7 January 2021

Acute invasive rhinocerebral zygomycosis in an otherwise healthy patient: case report and review

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011119018112

7 January 2021

https://api.crossref.org/works/10.1023%2FA%3A1011119018112

1 reference

7 January 2021

Recovery from rhinocerebral mucormycosis with carotid artery occlusion: a pediatric case and review of the literature

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011119018112

7 January 2021

Isolated pontine infarction due to rhinocerebral mucormycosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011119018112

7 January 2021

A case of fatal rhinocerebral mucormycosis with new onset diabetic keto-acidosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011119018112

7 January 2021

Treatment of rhinocerebral mucormycosis with intravenous interstitial, and cerebrospinal fluid administration of amphotericin B: case report

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011119018112

7 January 2021

Rhinocerebral mucormycosis: use of liposomal amphotericin B.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011119018112

7 January 2021

Successful treatment of rhinocerebral mucormycosis by a combination of aggressive surgical debridement and the use of systemic liposomal amphotericin B and local therapy with nebulized amphotericin--a case report

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011119018112

7 January 2021

Intracranial Complications of Mucormycosis: An Experimental Model and Clinical Review

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011119018112

7 January 2021

Cutaneous mucormycosis in a heart transplant patient associated with a peripheral catheter

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011119018112

7 January 2021

Treatment of deep mycoses with liposomal amphotericin B

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011119018112

7 January 2021

Long-term survival of a patient with invasive cranial base rhinocerebral mucormycosis treated with combined endovascular, surgical, and medical therapies: case report

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011119018112

7 January 2021

Endoscopic sinus surgery for rhinocerebral mucormycosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011119018112

7 January 2021

Rhinocerebral mucormycosis in patients with burns: case report and review of the literature.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011119018112

7 January 2021

Mucormycosis in trauma patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011119018112

7 January 2021

Mucormycosis: emerging prominence of cutaneous infections

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011119018112

7 January 2021

Identifiers

DOI

10.1023/A:1011119018112

1 reference

22 September 2017

1 reference